从1968年到2023年,美国的中风死亡率:疾病预防控制中心 (CDC) 的WONDER分析
Saad Ahmed Waqas1, Jazza Aamir1, Dua Ali1
1Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
概括
在过去的五十年中,中风死亡率显著下降,但最近的死亡率有所增加,特别是在年轻人和少数群体中. 针对性的公共卫生干预措施对于解决这些持续存在的差异至关重要.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 心血管疾病研究研究
背景情况:
- 在美国,中风是导致死亡的首要原因,50年来病例的模式一直在变化.
- 对1968-2023年中风死亡率趋势的分析揭示了显著的人口和地理差异.
研究的目的:
- 分析美国从1968年到2023年的中风死亡率趋势.
- 识别和检查中风死亡率在年龄,性别,种族和地理区域的差异.
主要方法:
- 使用国家死亡率数据进行基于人口的描述性研究 (CDC WONDER).
- 使用国际疾病分类 (ICD) 代码 (1968-2023) 分析中风死亡 (年龄≥25岁).
- 根据年龄调整的死亡率 (AAMR) 的计算和使用Joinpoint回归的时间趋势分析.
主要成果:
- 总中风死亡人数:8,933,826人 (1968年至2023年).
- 整体AAMR从每10万人口的250.6下降到60.0,在2011年之后显著上升.
- 观察到持续的差异:男性,黑人和美国南部的比例更高. 2014年后,缺血性中风的发生率增加,而出血性中风的发生率继续下降.
结论:
- 尽管长期减少,中风死亡率显示最近的增加,特别是在特定的人口和地区.
- 调查结果强调,迫切需要有针对性的公共卫生干预措施,以减轻中风差异.
- 解决年轻成年人和少数群体中中风死亡率上升的问题是关键的公共卫生优先事项.
相关概念视频
Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Interpreting Run Charts
Run charts, essentially line graphs plotted over time, serve as fundamental yet effective tools for process analysis. They chronicle data sequentially, facilitating the identification of trends, shifts, or cyclical movements. This graphical representation is instrumental in determining whether a process is stable or exhibits signs of potential instability indicative of special cause variation. In the healthcare domain, run charts depict infection rates over time, enabling hospitals to monitor...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...


